neferine has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, CY; Lohanathan, BP; Rathinasamy, B; Viswanadha, VP | 1 |
| Chen, X; Du, Z; Liang, E; Liu, X; Lu, J; Song, X; Zhang, M; Zhang, Y; Zhao, Y | 1 |
2 other study(ies) available for neferine and Cirrhosis
| Article | Year |
|---|---|
Neferine attenuates doxorubicin-induced fibrosis and hypertrophy in H9c2 cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Benzylisoquinolines; Cardiotoxicity; Doxorubicin; Fibrosis; Humans; Hypertrophy; Matrix Metalloproteinase 2; Myocytes, Cardiac; Transforming Growth Factor beta1; Tumor Suppressor Protein p53 | 2022 |
Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice.
Topics: Animals; Benzylisoquinolines; Cell Cycle; Cell Differentiation; Cell Movement; Cell Proliferation; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drugs, Chinese Herbal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Glucose; Heart Rate; Male; Mice; Mice, Inbred C57BL; Myocardium; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2016 |